Logo image
Inhibition of the TRAIL death receptor by CMV reveals its importance in NK Cell-Mediated antiviral defense
Journal article   Open access   Peer reviewed

Inhibition of the TRAIL death receptor by CMV reveals its importance in NK Cell-Mediated antiviral defense

S. Verma, A. Loewendorf, Q. Wang, B. McDonald, A. Redwood and C.A. Benedict
PLoS Pathogens, Vol.10(8), e1004268
2014
pdf
TRAIL.pdfDownloadView
Published (Version of Record) Open Access
url
Free to Read *No subscription requiredView

Abstract

TNF-related apoptosis inducing ligand (TRAIL) death receptors (DR) regulate apoptosis and inflammation, but their role in antiviral defense is poorly understood. Cytomegaloviruses (CMV) encode many immune-modulatory genes that shape host immunity, and they utilize multiple strategies to target the TNF-family cytokines. Here we show that the m166 open reading frame (orf) of mouse CMV (MCMV) is strictly required to inhibit expression of TRAIL-DR in infected cells. An MCMV mutant lacking m166 expression (m166stop) is severely compromised for replication in vivo, most notably in the liver, and depleting natural killer (NK) cells, or infecting TRAIL-DR−/− mice, restored MCMV-m166stop replication completely. These results highlight the critical importance for CMV to have evolved a strategy to inhibit TRAIL-DR signaling to thwart NK-mediated defenses.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

113 File views/ downloads
45 Record Views

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
International collaboration
Citation topics
1 Clinical & Life Sciences
1.6 Immunology
1.6.1021 Natural Killer Cells
Web Of Science research areas
Microbiology
Parasitology
Virology
ESI research areas
Microbiology
Logo image